Clinical TrialsSearch results
Number of results: 367
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Completed
- A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
- Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome
- Contact Local
- 2021-07-19
Recruiting
- Phase 3 Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (SUCCESSOR-1)
- Relapsed or Refractory Multiple Myeloma (RRMM)
- Nishio Mitsufumi
- 2023-12-04
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Randomised controlled trial of multiple drugs combined therapy for diffuse IgA nephropathy
- Refractory IgA nephropathy
- Japanese Study Group of Multiple drug therapy for IgAN
- 2006-03-31
Other
- Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
- Refractory (drug resistant) nephrotic syndrome
- the Japanese Society of Kidney and Lipids Research
- 2007-11-01
Other
- A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.
- Rectal Cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2006-04-01
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Recruiting
- Utility and safety of preoperative lesion marking using ICGin robotic-assisted rectal cancer surgery
- Rectal cancer
- Nonaka Takashi
- 2024-11-21
Other
- Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)
- pulmonary neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28